Published in J Med Microbiol on November 01, 2002
Multilocus sequence typing scheme that provides both species and strain differentiation for the Burkholderia cepacia complex. J Clin Microbiol (2005) 2.17
Development of a recA gene-based identification approach for the entire Burkholderia genus. Appl Environ Microbiol (2005) 1.55
Molecular analysis of Burkholderia cepacia complex isolates from a Portuguese cystic fibrosis center: a 7-year study. J Clin Microbiol (2003) 1.37
Multilocus sequence typing breathes life into a microbial metagenome. PLoS One (2006) 1.23
Elucidating global epidemiology of Burkholderia multivorans in cases of cystic fibrosis by multilocus sequence typing. J Clin Microbiol (2007) 1.04
Burkholderia cenocepacia vaginal infection in patient with smoldering myeloma and chronic hepatitis C. Emerg Infect Dis (2004) 1.01
Development of a species-specific fur gene-based method for identification of the Burkholderia cepacia complex. J Clin Microbiol (2007) 0.99
Molecular typing of, and distribution of genetic markers among, Burkholderia cepacia complex isolates from Brazil. J Clin Microbiol (2003) 0.96
Characterization of SodC, a periplasmic superoxide dismutase from Burkholderia cenocepacia. Infect Immun (2007) 0.93
Fourier transform infrared spectroscopy for rapid identification of nonfermenting gram-negative bacteria isolated from sputum samples from cystic fibrosis patients. J Clin Microbiol (2008) 0.93
Genetic diversity of Burkholderia contaminans isolates from cystic fibrosis patients in Argentina. J Clin Microbiol (2012) 0.91
Revised approach for identification of isolates within the Burkholderia cepacia complex and description of clinical isolates not assigned to any of the known genomovars. J Clin Microbiol (2007) 0.85
rpsU-based discrimination within the genus Burkholderia. Eur J Microbiol Immunol (Bp) (2014) 0.84
Identification, molecular characterisation and antimicrobial susceptibility of genomovars of the Burkholderia cepacia complex in Spain. Eur J Clin Microbiol Infect Dis (2012) 0.83
Isolation and characterization of Burkholderia rinojensis sp. nov., a non-Burkholderia cepacia complex soil bacterium with insecticidal and miticidal activities. Appl Environ Microbiol (2013) 0.83
Differentiation of species combined into the Burkholderia cepacia complex and related taxa on the basis of their fatty acid patterns. J Clin Microbiol (2006) 0.82
Diversity of the parB and repA genes of the Burkholderia cepacia complex and their utility for rapid identification of Burkholderia cenocepacia. BMC Microbiol (2008) 0.82
Correlation of rpsU Gene Sequence Clusters and Biochemical Properties, Gc-Ms Spectra and Resistance Profiles of Clinical Burkholderia Spp. Isolates. Eur J Microbiol Immunol (Bp) (2016) 0.81
Identification of potential diagnostic markers among Burkholderia cenocepacia and B. multivorans supernatants. J Clin Microbiol (2010) 0.80
Diversity of Burkholderia cepacia complex from the Moso bamboo (Phyllostachys edulis) rhizhosphere soil. Curr Microbiol (2010) 0.80
Polyphasic characterisation of Burkholderia cepaciacomplex species isolated from children with cystic fibrosis. Mem Inst Oswaldo Cruz (2016) 0.79
PCR detection of Burkholderia multivorans in water and soil samples. BMC Microbiol (2016) 0.75
Prevalence and Identification of Burkholderia pseudomallei and Near-Neighbor Species in the Malabar Coastal Region of India. PLoS Negl Trop Dis (2016) 0.75
Burkholderia cepacia complex in cystic fibrosis in a Brazilian reference center. Med Microbiol Immunol (2017) 0.75
DNA-DNA hybridization values and their relationship to whole-genome sequence similarities. Int J Syst Evol Microbiol (2007) 12.76
Opinion: Re-evaluating prokaryotic species. Nat Rev Microbiol (2005) 7.19
Diversity and significance of Burkholderia species occupying diverse ecological niches. Environ Microbiol (2003) 4.01
Characterization of unusual bacteria isolated from respiratory secretions of cystic fibrosis patients and description of Inquilinus limosus gen. nov., sp. nov. J Clin Microbiol (2002) 3.44
Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives. Gut (2011) 3.36
Burkholderia xenovorans LB400 harbors a multi-replicon, 9.73-Mbp genome shaped for versatility. Proc Natl Acad Sci U S A (2006) 3.07
Comparison of multiple methods for quantification of microbial biofilms grown in microtiter plates. J Microbiol Methods (2007) 2.92
Taxonomy of the genus Cupriavidus: a tale of lost and found. Int J Syst Evol Microbiol (2004) 2.80
The genome of Burkholderia cenocepacia J2315, an epidemic pathogen of cystic fibrosis patients. J Bacteriol (2008) 2.71
Taxon K, a complex within the Burkholderia cepacia complex, comprises at least two novel species, Burkholderia contaminans sp. nov. and Burkholderia lata sp. nov. Int J Syst Evol Microbiol (2009) 2.61
Burkholderia cenocepacia sp. nov.--a new twist to an old story. Res Microbiol (2003) 2.49
PCR-based assay for differentiation of Pseudomonas aeruginosa from other Pseudomonas species recovered from cystic fibrosis patients. J Clin Microbiol (2004) 2.31
Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis, Canada. Emerg Infect Dis (2002) 2.26
Multilocus sequence typing scheme that provides both species and strain differentiation for the Burkholderia cepacia complex. J Clin Microbiol (2005) 2.17
Comparative evaluation of the BD Phoenix and VITEK 2 automated instruments for identification of isolates of the Burkholderia cepacia complex. J Clin Microbiol (2002) 2.16
Burkholderia cepacia complex infection in patients with cystic fibrosis. J Med Microbiol (2002) 2.07
Burkholderia latens sp. nov., Burkholderia diffusa sp. nov., Burkholderia arboris sp. nov., Burkholderia seminalis sp. nov. and Burkholderia metallica sp. nov., novel species within the Burkholderia cepacia complex. Int J Syst Evol Microbiol (2008) 1.93
Legume symbiotic nitrogen fixation by beta-proteobacteria is widespread in nature. J Bacteriol (2003) 1.88
Infection by Ralstonia species in cystic fibrosis patients: identification of R. pickettii and R. mannitolilytica by polymerase chain reaction. Emerg Infect Dis (2002) 1.88
An epidemic Burkholderia cepacia complex strain identified in soil. Lancet (2002) 1.88
Ribosomal DNA-directed PCR for identification of Achromobacter (Alcaligenes) xylosoxidans recovered from sputum samples from cystic fibrosis patients. J Clin Microbiol (2002) 1.87
Towards a prokaryotic genomic taxonomy. FEMS Microbiol Rev (2005) 1.87
Burkholderia anthina sp. nov. and Burkholderia pyrrocinia, two additional Burkholderia cepacia complex bacteria, may confound results of new molecular diagnostic tools. FEMS Immunol Med Microbiol (2002) 1.86
Fluoroquinolone resistance in Mycobacterium tuberculosis and mutations in gyrA and gyrB. Antimicrob Agents Chemother (2009) 1.82
Diversity and occurrence of Burkholderia spp. in the natural environment. FEMS Microbiol Rev (2008) 1.77
Epidemiology of Pseudomonas aeruginosa in cystic fibrosis in British Columbia, Canada. Am J Respir Crit Care Med (2002) 1.76
Updated version of the Burkholderia cepacia complex experimental strain panel. J Clin Microbiol (2003) 1.74
Bacterial whole-genome sequences: minimal information and strain availability. Microbiology (2004) 1.71
Kerstersia gyiorum gen. nov., sp. nov., a novel Alcaligenes faecalis-like organism isolated from human clinical samples, and reclassification of Alcaligenes denitrificans Rüger and Tan 1983 as Achromobacter denitrificans comb. nov. Int J Syst Evol Microbiol (2003) 1.67
Intragenomic heterogeneity between multiple 16S ribosomal RNA operons in sequenced bacterial genomes. FEMS Microbiol Lett (2003) 1.62
The Burkholderia cepacia epidemic strain marker is part of a novel genomic island encoding both virulence and metabolism-associated genes in Burkholderia cenocepacia. Infect Immun (2004) 1.60
Proposal to accommodate Burkholderia cepacia genomovar VI as Burkholderia dolosa sp. nov. Int J Syst Evol Microbiol (2004) 1.58
Dynamics and biodiversity of populations of lactic acid bacteria and acetic acid bacteria involved in spontaneous heap fermentation of cocoa beans in Ghana. Appl Environ Microbiol (2007) 1.55
Development of a recA gene-based identification approach for the entire Burkholderia genus. Appl Environ Microbiol (2005) 1.55
Ultrastructure of Proteus mirabilis swarmer cell rafts and role of swarming in catheter-associated urinary tract infection. Infect Immun (2004) 1.50
Classification of the biphenyl- and polychlorinated biphenyl-degrading strain LB400T and relatives as Burkholderia xenovorans sp. nov. Int J Syst Evol Microbiol (2004) 1.50
Epidemic spread of Pandoraea apista, a new pathogen causing severe lung disease in cystic fibrosis patients. Pediatr Pulmonol (2003) 1.50
Taxonomic study of Weissella confusa and description of Weissella cibaria sp. nov., detected in food and clinical samples. Int J Syst Evol Microbiol (2002) 1.49
Resistance of planktonic and biofilm-grown Burkholderia cepacia complex isolates to the transition metal gallium. J Antimicrob Chemother (2008) 1.48
Burkholderia cepacia complex bacteria from clinical and environmental sources in Italy: genomovar status and distribution of traits related to virulence and transmissibility. J Clin Microbiol (2002) 1.48
Quorum sensing inhibitors increase the susceptibility of bacterial biofilms to antibiotics in vitro and in vivo. Antimicrob Agents Chemother (2011) 1.46
In vitro and in vivo model systems to study microbial biofilm formation. J Microbiol Methods (2010) 1.46
Involvement of a plasmid-encoded type IV secretion system in the plant tissue watersoaking phenotype of Burkholderia cenocepacia. J Bacteriol (2004) 1.40
Mucispirillum schaedleri gen. nov., sp. nov., a spiral-shaped bacterium colonizing the mucus layer of the gastrointestinal tract of laboratory rodents. Int J Syst Evol Microbiol (2005) 1.40
Recovery of Herbaspirillum species from persons with cystic fibrosis. J Clin Microbiol (2008) 1.39
Influence of taxonomic status on the in vitro antimicrobial susceptibility of the Burkholderia cepacia complex. J Antimicrob Chemother (2002) 1.38
Burkholderia fungorum septicemia. Emerg Infect Dis (2005) 1.37
Development and evaluation of different normalization strategies for gene expression studies in Candida albicans biofilms by real-time PCR. BMC Mol Biol (2006) 1.37
Molecular analysis of Burkholderia cepacia complex isolates from a Portuguese cystic fibrosis center: a 7-year study. J Clin Microbiol (2003) 1.37
Environmental Burkholderia cepacia complex isolates in human infections. Emerg Infect Dis (2007) 1.36
Gene expression changes linked to antimicrobial resistance, oxidative stress, iron depletion and retained motility are observed when Burkholderia cenocepacia grows in cystic fibrosis sputum. BMC Infect Dis (2008) 1.36
Comparison of three assays for the quantification of Candida biomass in suspension and CDC reactor grown biofilms. J Microbiol Methods (2005) 1.35
Characterization of the cciIR quorum-sensing system in Burkholderia cenocepacia. Infect Immun (2005) 1.35
In vitro activity of ceftazidime, ciprofloxacin, meropenem, minocycline, tobramycin and trimethoprim/sulfamethoxazole against planktonic and sessile Burkholderia cepacia complex bacteria. J Antimicrob Chemother (2009) 1.30
Identification of a novel virulence factor in Burkholderia cenocepacia H111 required for efficient slow killing of Caenorhabditis elegans. Infect Immun (2004) 1.30
Classification of Ralstonia pickettii-like isolates from the environment and clinical samples as Ralstonia insidiosa sp. nov. Int J Syst Evol Microbiol (2003) 1.28
A sensor kinase recognizing the cell-cell signal BDSF (cis-2-dodecenoic acid) regulates virulence in Burkholderia cenocepacia. Mol Microbiol (2010) 1.27
Bayesian modeling of recombination events in bacterial populations. BMC Bioinformatics (2008) 1.27
Expanded multilocus sequence typing for burkholderia species. J Clin Microbiol (2009) 1.26
Identification and distribution of Achromobacter species in cystic fibrosis. J Cyst Fibros (2012) 1.25
Multilocus sequence typing breathes life into a microbial metagenome. PLoS One (2006) 1.23
Use of PCR analyses to define the distribution of Ralstonia species recovered from patients with cystic fibrosis. J Clin Microbiol (2005) 1.23
Molecular mechanisms of chlorhexidine tolerance in Burkholderia cenocepacia biofilms. Antimicrob Agents Chemother (2011) 1.22
Burkholderia pseudomultivorans sp. nov., a novel Burkholderia cepacia complex species from human respiratory samples and the rhizosphere. Syst Appl Microbiol (2013) 1.21
Population dynamics and metabolite target analysis of lactic acid bacteria during laboratory fermentations of wheat and spelt sourdoughs. Appl Environ Microbiol (2007) 1.21
Biofilm formation by Propionibacterium acnes is associated with increased resistance to antimicrobial agents and increased production of putative virulence factors. Res Microbiol (2007) 1.19
A multilocus sequence typing scheme implies population structure and reveals several putative novel Achromobacter species. J Clin Microbiol (2012) 1.19
Assessment of the genetic diversity among arcobacters isolated from poultry products by using two PCR-based typing methods. Appl Environ Microbiol (2002) 1.18
Cinnamaldehyde and cinnamaldehyde derivatives reduce virulence in Vibrio spp. by decreasing the DNA-binding activity of the quorum sensing response regulator LuxR. BMC Microbiol (2008) 1.18
'Candidatus glomeribacter gigasporarum' gen. nov., sp. nov., an endosymbiont of arbuscular mycorrhizal fungi. Int J Syst Evol Microbiol (2003) 1.17
Prevalence of vulvovaginal candidiasis and susceptibility to fluconazole in women. Am J Obstet Gynecol (2002) 1.16
Burkholderia nodosa sp. nov., isolated from root nodules of the woody Brazilian legumes Mimosa bimucronata and Mimosa scabrella. Int J Syst Evol Microbiol (2007) 1.16
Ralstonia respiraculi sp. nov., isolated from the respiratory tract of cystic fibrosis patients. Int J Syst Evol Microbiol (2003) 1.15
Deciphering the role of RND efflux transporters in Burkholderia cenocepacia. PLoS One (2011) 1.14
Extracting phylogenetic information from whole-genome sequencing projects: the lactic acid bacteria as a test case. Microbiology (2003) 1.14